|Articles|January 1, 1998
Supplements and Featured Publications
- A Managed Care Appraisal of Atypical Agents in the Treatment of Psychoses
- Volume 4
- Issue 1 Suppl
Atypical Antipsychotics in the Managed Care Era
Advertisement
Articles in this issue
about 28 years ago
Common Treatment Goals: Switching Antipsychoticsabout 28 years ago
Antipsychotics : Present and Futureabout 28 years ago
CME Quizabout 28 years ago
Selected Abstractsabout 28 years ago
Bibliographyabout 28 years ago
Participating Facultyabout 28 years ago
Introduction - The Routine Use of Atypical Antipsychoticsabout 28 years ago
Atypical Antipsychotics and Formulary Decisionsabout 28 years ago
Chronic Ambulatory Outpatients and Four-Vector ManagementNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
